New Partnership Brings Innovative Single Cell Solutions to Researchers Across Japan SEATTLE — Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced an agreement with Tokyo-based SCRUM Inc. to expand its presence in Japan’s research community. This collaboration will provide researchers in academia and industry with full access to Parse’s […]

Akoya’s technology to generate data for a first-of-its-kind Biobank and Data Repository for Cancer Equity Research, funded through the Cancer Grand Challenges initiative The unprecedented scale of the initiative requires the high plex and high throughput of Akoya’s PhenoCycler-Fusion platform to process thousands of patients’ samples MARLBOROUGH, Mass. — Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial […]

Collaboration to enable cost-effective end-to-end genotyping across large animal and plant populations Companies to present poster at AGBT-Ag SOUTH SAN FRANCISCO, Calif. & ANN ARBOR, Mich. —  Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Curio Genomics, a pioneer in genomics […]

Strategic partnership marks launch of early access program offering rapid, long, clonal gene synthesis and high-complexity genes up to 15 kb CORALVILLE, Iowa and SAN CARLOS Calif. — Global genomics solutions leader Integrated DNA Technologies (IDT) and Elegen, the leader in next-generation DNA manufacturing, are teaming up to offer IDT customers early access to Elegen’s ENFINIA™ Plasmid DNA, […]

“This strategic partnership aligns with both companies’ missions to streamline genomic analysis by delivering cutting-edge solutions that accelerate discoveries and clinical decision-making. By leveraging Genomenon’s powerful datasets, Genomize users will gain access to deeper variant interpretation capabilities, driving innovation in personalized medicine.” Integration of Mastermind and Cancer Knowledgebase (CKB) Data To Drive Unprecedented Efficiency in […]

Espoo — Euformatics has signed a commercial contract with India-based genomics company Bencos Healthcare Solution Pvt Ltd to jointly develop clinical NGS bioinformatics solutions. This partnership aims at powering the large and fast-growing clinical genomics market in India. The scope of the collaboration covers the infusion of Euformatics tertiary analysis of NGS data with Bencos Healthcare […]

New alliance for advanced biological imaging aimed at enhancing some of the world’s most innovative structural cell biology capabilities to help scientists answer pressing research questions WALTHAM, Mass. —  Thermo Fisher Scientific Inc., the world leader in serving science, has announced a Technology Alliance Agreement with the Chan Zuckerberg Institute for Advanced Biological Imaging (CZ […]

License agreement provides Jumpcode Genomics access to CRISPR gene editing technology to enhance next-generation sequencing capabilities DUBLIN and SAN DIEGO — ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Jumpcode Genomics (‘Jumpcode’), a life science tools company improving and reducing the cost of next-generation sequencing technology, today announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants Jumpcode access […]

Cambridge, UK and Wuxi, China – SPT Labtech, a renowned multinational innovator specializing in automated instrumentation and consumables, joined forces with Biortus Biosciences Co., Ltd., a global leader in integrated capabilities spanning from gene to structural analysis, to inaugurate their strategic partnership and unveil the “Joint Laboratory of Structural Biology” at I-Campus. This collaboration marks […]

BC Platforms is a partner in BRECISE (Biomarker Research and Evaluation for Clinical Implementation and Supporting Systems Enhancement), a five-year multidisciplinary research initiative co-funded by the Innovative Health Initiative (IHI) under the Horizon Europe programme. The project officially launched in Madrid on March 20, 2025, and runs from January 1, 2025, through 2029. What Is […]